← Eichor
Study identifier: NCT07220005 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization

Condition: Stroke · Arm Weakness as a Consequence of Stroke · Upper Extremity Hemiparesis  ·  Sponsor: Duke University

PhaseNA
Planned participants24
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this research study is to optimize the parameter of Low-Intensity Focused Ultrasound Stimulation (LIFUS) that is most effective in changing cortical excitability and motor learning skills in patients who suffered a stroke. The researchers hope to answer two questions. * with increasing power, would LIFUS be more effective? * with the same power, what LIFUS timing is the best For Aim 1, the study will compare 8, 4 W/cm\^2 to a zero(sham) stimulation to see if higher power is the better. For Aim 2, the study will compare 500 vs 1000 vs 2000 Hz "timing" to see which one is better.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Research Coordinator  ·  919-668-7597  ·  megan.gonzalez@duke.edu

Ziping Huang, MS  ·  ziping.huang@duke.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Duke University HospitalDurham, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07220005